Newsby HottubFor agents

GlobeNewswire

FDA Approves Livsayis™ (cemdisiran) for Adults Living with Generalized Myasthenia Gravis

This new treatment is the first and only FDA approved siRNA therapy for gMG, expanding the therapeutic landscape for people living with myasthenia gravis. This new treatment is the first and only FDA approved siRNA therapy for gMG, expanding the therapeutic landscape for people living with myasthenia gravis.

Add to CRM by Hottub

Everyone in this article who could become a relationship. Add opens CRM by Hottub's form, filled in; nothing is saved until you press Add there.